June 7, 2026
Scientists test an anti
KeAi Communications Co., Ltd.. "Scientists test an anti-aging cream that actually works." ScienceDaily. ScienceDaily, 15 September 2025. <www.sciencedaily.com/releases/2025/09/250914205851.htm>.
Naujausios naujienos ir straipsniai apie genetinius tyrimus
June 7, 2026
KeAi Communications Co., Ltd.. "Scientists test an anti-aging cream that actually works." ScienceDaily. ScienceDaily, 15 September 2025. <www.sciencedaily.com/releases/2025/09/250914205851.htm>.
June 6, 2026
Researchers at NYU Langone Health have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This non-invasive test uses genetic biomarkers to identify potential cancer returns, potentially improving treatment outcomes for patients.
June 6, 2026
NYU Langone Health / NYU Grossman School of Medicine. "Gene-based blood test for melanoma may catch early signs of cancer's return." ScienceDaily. ScienceDaily, 16 April 2025. <www.sciencedaily.com...
June 6, 2026
Researchers have developed a gene-based blood test that may help detect the early signs of melanoma recurrence. This innovative test has shown promise in identifying genetic markers associated with cancer's return.
June 6, 2026
Researchers have identified micro-nano-plastics in the arterial plaque of individuals with atherosclerosis, a condition characterized by the buildup of plaque in artery walls. This discovery raises concerns about the potential impact of plastic pollution on cardiovascular health.
June 6, 2026
American Heart Association. "Micro-nano-plastics found in artery-clogging plaque in the neck." ScienceDaily. ScienceDaily, 23 April 2025. <www.sciencedaily.com/releases/2025/04/250423112651.htm>...
June 6, 2026
Researchers have found micro-nano-plastics present in artery-clogging plaque in the neck, raising concerns about the potential impact of plastic pollution on cardiovascular health. The study suggests that exposure to microplastics may contribute to the development of atherosclerosis.
June 6, 2026
Researchers at the Salk Institute have identified estrogen-related receptors as potential therapeutic targets for metabolic and muscular disorders. These findings could lead to new treatments for conditions such as diabetes, obesity, and muscle wasting diseases.
June 6, 2026
Researchers at the Salk Institute have identified estrogen-related receptors as potential targets for treating metabolic and muscular disorders. These receptors play a crucial role in regulating energy metabolism and muscle function.